Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2023 on Monday, March 4, 2024, After Close of U.S.-Based Financial Markets

Rhea-AI Summary

Nektar Therapeutics (NKTR) is set to announce its Q4 and full-year 2023 financial results on March 4, 2024. The conference call hosted by President and CEO Howard Robin will provide insights into the company's performance. Investors can access the live webcast and replay through the Nektar website.

SAN FRANCISCO, Feb. 26, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2023 on Monday, March 4, 2024, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.

The press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the Home Page and Investors section of the Nektar website: http://ir.nektar.com/. The web broadcast of the conference call will be available for replay through April 4, 2024.

To access the conference call, please pre-register at Nektar Earnings Call Registration. All registrants will receive dial-in information and a PIN allowing them to access the live call.

About Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in immunology and oncology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional manufacturing operations in Huntsville, Alabama. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Contact:

For Investors:

Vivian Wu of Nektar Therapeutics
628-895-0661

For Media:

David Rosen of Argot Partners
(212) 600-1902
david.rosen@argotpartners.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/nektar-to-announce-financial-results-for-the-fourth-quarter-and-year-ended-2023-on-monday-march-4-2024-after-close-of-us-based-financial-markets-302071648.html

SOURCE Nektar Therapeutics

FAQ

When will Nektar Therapeutics announce its financial results for Q4 and full-year 2023?

Nektar Therapeutics will announce its financial results for Q4 and full-year 2023 on March 4, 2024.

Who will host the conference call to review the financial results?

Howard Robin, President and Chief Executive Officer of Nektar Therapeutics, will host the conference call to review the financial results.

Where can investors access the live webcast of the conference call?

Investors can access the live webcast of the conference call through a link on the Home Page and Investors section of the Nektar website: http://ir.nektar.com/.

How long will the web broadcast of the conference call be available for replay?

The web broadcast of the conference call will be available for replay through April 4, 2024.

How can registrants access the conference call?

Registrants can pre-register at Nektar Earnings Call Registration to receive dial-in information and a PIN for accessing the live call.